Product
RO7198457
2 clinical trials
3 indications
Indication
Colorectal Cancer Stage IIIndication
Colorectal Cancer Stage IIIIndication
Pancreatic CancerClinical trial
A Multi-site, Open-label, Phase II, Randomized, Controlled Trial to Compare the Efficacy of RO7198457 Versus Watchful Waiting in Resected, Stage II (High Risk) and Stage III Colorectal Cancer Patients Who Are ctDNA Positive Following ResectionStatus: Recruiting, Estimated PCD: 2026-02-01
Clinical trial
Phase 1 Clinical Trial of Personalized Neoantigen Tumor Vaccines and Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Surgically Resected Pancreatic CancerStatus: Active (not recruiting), Estimated PCD: 2024-11-11